Trial Profile
Investigation of the dose-response relationship of different doses of erythropoietin on frataxin in Friedreich's ataxia [Untersuchung der Dosis-Wirk-Beziehung unterschiedlicher Erythropoetin-Dosen auf Frataxin bei Friedreich Ataxie]
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Nov 2020
Price :
$35
*
At a glance
- Drugs Epoetin beta (Primary)
- Indications Friedreich's ataxia
- Focus Pharmacodynamics
- 28 Nov 2020 Status changed from recruiting to completed.
- 30 Aug 2011 New trial record